Business
Scotland’s Public Health Minister visit
Genedrive plc announced that its Genedrive® MT-RNR1 ID Kit, a test to reduce the risk of deafness in newborns, will be implemented nationally in Scotland. The rollout, funded by the Scottish Government with £0.8 million, begins in September 2025 at the Royal Hospital for Children in Glasgow, expanding to other hospitals shortly after. Over the next 18 months, the kit will be introduced to all territorial health boards with neonatal units. It's anticipated that over 3,000 newborn babies will be tested in the first year. The initiative follows an assessment by the Chief Scientist Office and the Scottish Health Technologies Group. Disclaimer*
About this update from Genedrive Plc
[{"type":"text","content":"\n\ngenedrive plc\n(\"genedrive\" or the \"Company\")\n \nScotland's Public Health Minister visits NHSGGC ahead of the Genedrive® MT-RNR1 ID Kit national rollout launch\n \ngenedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, is pleased to note that the Genedrive® MT-RNR1 ID Kit, which reduces the risk of deafness in newborn babies is being introduced by NHS Greater Glasgow and Clyde (\"NHSGGC\") in September 2025 as part of the national rollout funded by the Scottish Government (Genetic test to prevent hearing loss in newborns to begin national rollout in NHS Greater Glasgow and Clyde - NHSGGC).\n \nThe Genedrive® MT-RNR1 ID Kit will start being used for babies requiring antibiotic treatment for infections within the Neonatal Intensive Care Unit at the Royal Hospital for Children (\"RHC\") in Glasgow next month, with the Royal Alexandra Hospital and Princess Royal Maternity Hospital to follow soon after. \n \nIt will be rolled out to all territorial health boards with neonatal units over the next 18 months. The initiative follows an assessment by the Chief Scientist Office funded Accelerated National Innovation Adoption (\"ANIA\") pathway, led by the Centre for Sustainable Delivery (\"CfSD\"), and a Programme for Government commitment from the Scottish Government to provide £0.8m to support national adoption. \n \nIt follows the ongoing UK-wide PALOH (Pharmacogenetics to Avoid Loss of Hearing) programme and assessment by the Scottish Health Technologies Group.\n \nScotland's Public Health Minister Jenni Minto visited the RHC neonatal unit to meet clinicians and representatives from the West of Scotland Innovation Hub (\"WoSIH\"), who have played a leading role in bringing the innovation to Scotland. Ms Minto also discussed the planned national rollout with members of the CfSD and once fully implemented, it is anticipated that more than 3,000 newborn babies would be tested during the first year. \n \nDr Gino Miele, CEO of genedrive plc, said: \"We are proud that NHS Scotland has sought to implement our interventional rapid genetic test nationally, ensuring over time that it is available to neonates across Scotland who might otherwise be at risk of hearing loss. We look forward to working closely with CfSD, ANIA and individual sites to imp...